معرفی
Prof. Dr. Bernd Bodenmiller is a full Professor in Quantitative Biomedicine at the University of Zurich (UZH) and ETH Zurich. He leads the Department of Quantitative Biomedicine (DQBM) and holds a dual professorship between UZH and ETH. His research focuses on developing experimental and computational methods to study cancer biology at the single-cell level, particularly using imaging mass cytometry (IMC) to analyze tumor ecosystems.
Education:
- Ph.D. in Systems Biology from ETH Zurich (2008)
- Postdoctoral training at ETH Zurich (2008-2009) and Stanford University (2009-2012)
Research Interests: Bodenmiller’s lab investigates the regulatory systems governing cancer development, including tumor heterogeneity, immune interactions, and spatial organization of tumor cells. They pioneer technologies like IMC and 3D imaging to map cellular phenotypes and spatial networks in tumors.
Key Contributions: The lab has developed tools such as the histoCAT software for IMC data analysis and contributed to understanding cancer-associated fibroblast heterogeneity. Their work bridges basic research with clinical applications, aiming to improve precision oncology through multi-omics approaches.
Awards:
- Friedrich Miescher Prize (2019)
- ERC Consolidator Grant (2019)
